
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.5B | $5.5B | $6.2B | $6.6B | $6.9B | |
Revenue Growth (YoY) | -11.99% | 22.17% | 10.89% | 7.26% | 5.22% | |
Cost of Revenues | $3B | $3.6B | $4B | $4.2B | $4.5B | |
Gross Profit | $1.5B | $1.9B | $2.1B | $2.4B | $2.5B | |
Gross Profit Margin | 34% | 34.48% | 34.88% | 36.15% | 35.68% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $515.6M | $603.9M | $644.6M | $677M | $696.9M | |
Other Inc / (Exp) | $140.5M | -$5.1M | $11.2M | -$19.3M | -$5.1M | |
Operating Expenses | $515.6M | $603.9M | $644.6M | $677M | $696.9M | |
Operating Income | $1B | $1.3B | $1.5B | $1.7B | $1.8B | |
Net Interest Expenses | $86.1M | $80.4M | $83.2M | $81.8M | $113M | |
EBT. Incl. Unusual Items | $1.1B | $1.2B | $1.4B | $1.6B | $1.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $209.9M | $233.1M | $269.2M | $293.2M | $285.4M | |
Net Income to Company | $872.4M | $990.1M | $1.2B | $1.3B | $1.4B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $872.4M | $990.1M | $1.2B | $1.3B | $1.4B | |
Basic EPS (Cont. Ops) | $3.80 | $4.29 | $5.04 | $5.70 | $5.95 | |
Diluted EPS (Cont. Ops) | $3.77 | $4.25 | $5.01 | $5.67 | $5.93 | |
Weighted Average Basic Share | $229.4M | $231M | $230.2M | $230.5M | $231.3M | |
Weighted Average Diluted Share | $231.2M | $232.8M | $231.5M | $231.5M | $232.2M | |
EBITDA | $1.4B | $1.6B | $1.8B | $2B | $2.2B | |
EBIT | $1.2B | $1.3B | $1.5B | $1.7B | $1.8B | |
Revenue (Reported) | $4.5B | $5.5B | $6.2B | $6.6B | $6.9B | |
Operating Income (Reported) | $1B | $1.3B | $1.5B | $1.7B | $1.8B | |
Operating Income (Adjusted) | $1.2B | $1.3B | $1.5B | $1.7B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.5B | $1.6B | $1.7B | $1.7B | |
Revenue Growth (YoY) | 1.13% | 19.97% | 9.5% | 8.71% | -0.24% | |
Cost of Revenues | $789.4M | $948.8M | $1B | $1.1B | $1.1B | |
Gross Profit | $426.4M | $509.7M | $574.6M | $591.5M | $625M | |
Gross Profit Margin | 35.07% | 34.95% | 35.98% | 34.07% | 36.09% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $133M | $156.5M | $169.1M | $174.3M | $170.2M | |
Other Inc / (Exp) | -$1.9M | $2.6M | -$5.4M | -$633K | -$1.6M | |
Operating Expenses | $133M | $156.5M | $169.1M | $174.3M | $170.2M | |
Operating Income | $293.3M | $353.2M | $405.5M | $417.2M | $454.8M | |
Net Interest Expenses | $18.9M | $19.6M | $20.6M | $35.3M | $19M | |
EBT. Incl. Unusual Items | $272.5M | $336.2M | $379.6M | $381.3M | $434.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.2M | $63.8M | $73.9M | $70.4M | $82.5M | |
Net Income to Company | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Basic EPS (Cont. Ops) | $0.95 | $1.18 | $1.33 | $1.35 | $1.52 | |
Diluted EPS (Cont. Ops) | $0.94 | $1.17 | $1.32 | $1.34 | $1.52 | |
Weighted Average Basic Share | $230.4M | $231.5M | $230.1M | $231.1M | $230.7M | |
Weighted Average Diluted Share | $232.3M | $233.1M | $231.2M | $232M | $231.5M | |
EBITDA | $356M | $433.9M | $482.5M | $514.6M | $559.6M | |
EBIT | $291.4M | $355.8M | $400.2M | $416.6M | $453.2M | |
Revenue (Reported) | $1.2B | $1.5B | $1.6B | $1.7B | $1.7B | |
Operating Income (Reported) | $293.3M | $353.2M | $405.5M | $417.2M | $454.8M | |
Operating Income (Adjusted) | $291.4M | $355.8M | $400.2M | $416.6M | $453.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.6B | $5.8B | $6.3B | $6.7B | $6.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3B | $3.8B | $4.1B | $4.3B | $4.4B | |
Gross Profit | $1.6B | $2B | $2.2B | $2.4B | $2.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $503.1M | $627.4M | $657.2M | $682.2M | $692.8M | |
Other Inc / (Exp) | -$3.2M | -$625K | $3.3M | -$14.5M | -$6M | |
Operating Expenses | $503.1M | $627.4M | $657.2M | $682.2M | $692.8M | |
Operating Income | $1.1B | $1.4B | $1.6B | $1.7B | $1.8B | |
Net Interest Expenses | $82.3M | $81M | $84.2M | $96.5M | $96.7M | |
EBT. Incl. Unusual Items | $1B | $1.3B | $1.5B | $1.6B | $1.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $192.6M | $243.7M | $279.3M | $289.7M | $297.5M | |
Net Income to Company | $811.1M | $1B | $1.2B | $1.3B | $1.4B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $811.1M | $1B | $1.2B | $1.3B | $1.4B | |
Basic EPS (Cont. Ops) | $3.53 | $4.51 | $5.20 | $5.73 | $6.13 | |
Diluted EPS (Cont. Ops) | $3.49 | $4.48 | $5.16 | $5.69 | $6.11 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.3B | $1.7B | $1.9B | $2.1B | $2.2B | |
EBIT | $1.1B | $1.4B | $1.6B | $1.7B | $1.8B | |
Revenue (Reported) | $4.6B | $5.8B | $6.3B | $6.7B | $6.9B | |
Operating Income (Reported) | $1.1B | $1.4B | $1.6B | $1.7B | $1.8B | |
Operating Income (Adjusted) | $1.1B | $1.4B | $1.6B | $1.7B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.5B | $1.6B | $1.7B | $1.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $789.4M | $948.8M | $1B | $1.1B | $1.1B | |
Gross Profit | $426.4M | $509.7M | $574.6M | $591.5M | $625M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $133M | $156.5M | $169.1M | $174.3M | $170.2M | |
Other Inc / (Exp) | -$1.9M | $2.6M | -$5.4M | -$633K | -$1.6M | |
Operating Expenses | $133M | $156.5M | $169.1M | $174.3M | $170.2M | |
Operating Income | $293.3M | $353.2M | $405.5M | $417.2M | $454.8M | |
Net Interest Expenses | $18.9M | $19.6M | $20.6M | $35.3M | $19M | |
EBT. Incl. Unusual Items | $272.5M | $336.2M | $379.6M | $381.3M | $434.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.2M | $63.8M | $73.9M | $70.4M | $82.5M | |
Net Income to Company | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Basic EPS (Cont. Ops) | $0.95 | $1.18 | $1.33 | $1.35 | $1.52 | |
Diluted EPS (Cont. Ops) | $0.94 | $1.17 | $1.32 | $1.34 | $1.52 | |
Weighted Average Basic Share | $230.4M | $231.5M | $230.1M | $231.1M | $230.7M | |
Weighted Average Diluted Share | $232.3M | $233.1M | $231.2M | $232M | $231.5M | |
EBITDA | $356M | $433.9M | $482.5M | $514.6M | $559.6M | |
EBIT | $291.4M | $355.8M | $400.2M | $416.6M | $453.2M | |
Revenue (Reported) | $1.2B | $1.5B | $1.6B | $1.7B | $1.7B | |
Operating Income (Reported) | $293.3M | $353.2M | $405.5M | $417.2M | $454.8M | |
Operating Income (Adjusted) | $291.4M | $355.8M | $400.2M | $416.6M | $453.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $346.8M | $345.4M | $409.8M | $374M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $597.5M | $829.2M | $919.3M | $1B | $948.8M | |
Inventory | $559.2M | $769.2M | $1B | $1.1B | $1B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $153M | $183.6M | $219.1M | $269.5M | $258.5M | |
Total Current Assets | $2.5B | $2.1B | $2.5B | $2.8B | $2.6B | |
Property Plant And Equipment | $693.8M | $787.1M | $805.9M | $1.1B | $1.1B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.2B | $5.2B | $5.4B | $6.4B | $6.6B | |
Other Intangibles | $2.6B | $3.4B | $3.3B | $4.2B | $3.9B | |
Other Long-Term Assets | $292.6M | $375M | $382.5M | $464.9M | $502.8M | |
Total Assets | $10.4B | $11.9B | $12.4B | $15B | $14.6B | |
Accounts Payable | $360.4M | $470.3M | $497.1M | $516.6M | $523.3M | |
Accrued Expenses | $180.4M | $190M | $175.3M | $213.5M | $215.6M | |
Current Portion Of Long-Term Debt | $132.3M | $315.1M | $226.1M | $1.4B | $654.3M | |
Current Portion Of Capital Lease Obligations | $44.9M | $47.4M | $46.4M | $61.1M | $54.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.1B | $1.6B | $1.6B | $2.9B | $2.1B | |
Long-Term Debt | $2.3B | $2.2B | $2.2B | $1.9B | $1.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.4B | $5B | $5B | $6.3B | $5B | |
Common Stock | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | |
Other Common Equity Adj | -$504.5M | -$470.4M | -$574.9M | -$484.9M | -$555.7M | |
Common Equity | $5.9B | $6.9B | $7.5B | $8.7B | $9.7B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $5.9B | $6.9B | $7.5B | $8.7B | $9.7B | |
Total Liabilities and Equity | $10.4B | $11.9B | $12.4B | $15B | $14.6B | |
Cash and Short Terms | $1.2B | $346.8M | $345.4M | $409.8M | $374M | |
Total Debt | $2.4B | $2.5B | $2.4B | $3.3B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $340.3M | $399.9M | $373.8M | $399M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $678.5M | $854.5M | $901.5M | $983.9M | $996.5M | |
Inventory | $604.3M | $866.5M | $1.1B | $1.1B | $1.1B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $167M | $211.6M | $247.5M | $290.5M | $295.7M | |
Total Current Assets | $2.6B | $2.3B | $2.7B | $2.8B | $2.8B | |
Property Plant And Equipment | $716M | $780.3M | $804.7M | $1.1B | $1.1B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.3B | $5.2B | $5.4B | $6.4B | $6.6B | |
Other Intangibles | $2.7B | $3.3B | $3.3B | $4.1B | $3.9B | |
Other Long-Term Assets | $297.2M | $387.6M | $393.8M | $472.9M | $509.2M | |
Total Assets | $10.6B | $12B | $12.6B | $14.9B | $14.9B | |
Accounts Payable | $397.1M | $504.2M | $526.1M | $517.4M | $534.4M | |
Accrued Expenses | $303.4M | $358.1M | $371.6M | $452M | $446.8M | |
Current Portion Of Long-Term Debt | $94.7M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $45.1M | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.1B | $1.6B | $1.5B | $2.5B | $2B | |
Long-Term Debt | $2.3B | $2.2B | $2.2B | $1.9B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5B | $5B | $4.9B | $5.9B | $4.9B | |
Common Stock | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | |
Other Common Equity Adj | -$512.9M | -$485.6M | -$548.4M | -$510.3M | -$517.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $6.1B | $6.9B | $7.8B | $9B | $10B | |
Total Liabilities and Equity | $10.6B | $12B | $12.6B | $14.9B | $14.9B | |
Cash and Short Terms | $1.1B | $340.3M | $399.9M | $373.8M | $399M | |
Total Debt | $2.4B | $2.5B | $2.2B | $2.9B | $1.9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $872.4M | $990.1M | $1.2B | $1.3B | $1.4B | |
Depreciation & Amoritzation | $255.3M | $292.1M | $319.4M | $337.6M | $382.9M | |
Stock-Based Compensation | $41.6M | $46.1M | $47.4M | $46.2M | $47.9M | |
Change in Accounts Receivable | $163.5M | -$172.8M | -$86.7M | $8.5M | $53.5M | |
Change in Inventories | $77.4M | -$129.6M | -$322.5M | $56.6M | $73M | |
Cash From Operations | $1.3B | $1.2B | $1.1B | $1.7B | $1.8B | |
Capital Expenditures | $74.2M | $110.7M | $139M | $136.2M | $127.1M | |
Cash Acquisitions | $128.8M | -$1.9B | -$426M | -$2.2B | -$117.5M | |
Cash From Investing | $61.6M | -$2.1B | -$552.8M | -$2.4B | -$244.8M | |
Dividends Paid (Ex Special Dividend) | -$165M | -$184.6M | -$202.2M | -$230.3M | -$258.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$102.9M | -$59.7M | -- | -- | -$300M | |
Repurchase of Common Stock | -$4.7M | -$14.7M | -$332.8M | -$7.8M | -$212M | |
Other Financing Activities | -$3.7M | -$5.6M | -$17M | -$7.7M | -$8.8M | |
Cash From Financing | -$539.4M | $39.3M | -$575.7M | $697.3M | -$1.6B | |
Beginning Cash (CF) | $393M | $1.2B | $346.8M | $345.4M | $409.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $803.2M | -$856M | $20.9M | $56.1M | -$18.4M | |
Ending Cash (CF) | $1.2B | $346.8M | $345.4M | $409.8M | $374M | |
Levered Free Cash Flow | $1.2B | $1B | $1B | $1.6B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Depreciation & Amoritzation | $64.6M | $78.1M | $82.4M | $98M | $106.4M | |
Stock-Based Compensation | $11.4M | $9.6M | $10.3M | $8.9M | $9.5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $284.4M | $201.3M | $386.5M | $410.2M | $417.5M | |
Capital Expenditures | $17.5M | $26.4M | $20M | $27.7M | $23.1M | |
Cash Acquisitions | -$263.9M | -- | -$99.3M | -- | -$103.2M | |
Cash From Investing | -$284.5M | -$14.9M | -$122.2M | -$21.4M | -$125.7M | |
Dividends Paid (Ex Special Dividend) | -$46M | -$50.8M | -$57.5M | -$64.7M | -$71.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$8M | -$156.7M | -$6.5M | -$6.9M | -$18M | |
Other Financing Activities | -$4M | -$8.2M | -$5.9M | -$6.5M | -$7.8M | |
Cash From Financing | -$84M | -$187.4M | -$215M | -$417.5M | -$277.7M | |
Beginning Cash (CF) | $1.2B | $346.8M | $345.4M | $409.8M | $374M | |
Foreign Exchange Rate Adjustment | -$5.1M | -$5.5M | $5.1M | -$7.3M | $10.9M | |
Additions / Reductions | -$84.1M | -$983K | $49.4M | -$28.7M | $14.1M | |
Ending Cash (CF) | $1.1B | $340.3M | $399.9M | $373.8M | $399M | |
Levered Free Cash Flow | $266.9M | $175M | $366.5M | $382.6M | $394.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $811.1M | $1B | $1.2B | $1.3B | $1.4B | |
Depreciation & Amoritzation | $253.8M | $305.6M | $323.7M | $353.3M | $391.3M | |
Stock-Based Compensation | $45.2M | $44.2M | $48.1M | $44.9M | $48.4M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.3B | $1.1B | $1.3B | $1.8B | $1.8B | |
Capital Expenditures | $74.8M | $119.5M | $132.6M | $143.9M | $122.5M | |
Cash Acquisitions | -$263.9M | -$1.7B | -$525.2M | -$2.1B | -$220.7M | |
Cash From Investing | -$338.4M | -$1.8B | -$660M | -$2.3B | -$349.1M | |
Dividends Paid (Ex Special Dividend) | -$169.9M | -$189.3M | -$208.9M | -$237.5M | -$265.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$12.6M | -$163.4M | -$182.6M | -$8.2M | -$223.1M | |
Other Financing Activities | -$6.3M | -$9.8M | -$14.7M | -$8.4M | -$10M | |
Cash From Financing | -$1.1B | -$64.1M | -$603.2M | $494.7M | -$1.5B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$153.9M | -$772.9M | $71.3M | -$22M | $24.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.2B | $957.9M | $1.2B | $1.6B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $219.2M | $272.4M | $305.7M | $310.9M | $351.8M | |
Depreciation & Amoritzation | $64.6M | $78.1M | $82.4M | $98M | $106.4M | |
Stock-Based Compensation | $11.4M | $9.6M | $10.3M | $8.9M | $9.5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $284.4M | $201.3M | $386.5M | $410.2M | $417.5M | |
Capital Expenditures | $17.5M | $26.4M | $20M | $27.7M | $23.1M | |
Cash Acquisitions | -$263.9M | -- | -$99.3M | -- | -$103.2M | |
Cash From Investing | -$284.5M | -$14.9M | -$122.2M | -$21.4M | -$125.7M | |
Dividends Paid (Ex Special Dividend) | -$46M | -$50.8M | -$57.5M | -$64.7M | -$71.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$8M | -$156.7M | -$6.5M | -$6.9M | -$18M | |
Other Financing Activities | -$4M | -$8.2M | -$5.9M | -$6.5M | -$7.8M | |
Cash From Financing | -$84M | -$187.4M | -$215M | -$417.5M | -$277.7M | |
Beginning Cash (CF) | $1.2B | $346.8M | $345.4M | $409.8M | $374M | |
Foreign Exchange Rate Adjustment | -$5.1M | -$5.5M | $5.1M | -$7.3M | $10.9M | |
Additions / Reductions | -$84.1M | -$983K | $49.4M | -$28.7M | $14.1M | |
Ending Cash (CF) | $1.1B | $340.3M | $399.9M | $373.8M | $399M | |
Levered Free Cash Flow | $266.9M | $175M | $366.5M | $382.6M | $394.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.